EP1212066A4 - Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids - Google Patents

Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids

Info

Publication number
EP1212066A4
EP1212066A4 EP00952657A EP00952657A EP1212066A4 EP 1212066 A4 EP1212066 A4 EP 1212066A4 EP 00952657 A EP00952657 A EP 00952657A EP 00952657 A EP00952657 A EP 00952657A EP 1212066 A4 EP1212066 A4 EP 1212066A4
Authority
EP
European Patent Office
Prior art keywords
lactobacillus
carbohydrates
lipids
pro
secreted proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP00952657A
Other languages
German (de)
French (fr)
Other versions
EP1212066A1 (en
Inventor
Pinaki Panigrahi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Maryland at Baltimore
Original Assignee
University of Maryland at Baltimore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Maryland at Baltimore filed Critical University of Maryland at Baltimore
Publication of EP1212066A1 publication Critical patent/EP1212066A1/en
Publication of EP1212066A4 publication Critical patent/EP1212066A4/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP00952657A 1999-08-09 2000-08-09 Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids Ceased EP1212066A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14779299P 1999-08-09 1999-08-09
US147792P 1999-08-09
PCT/US2000/021668 WO2001010448A1 (en) 1999-08-09 2000-08-09 Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids

Publications (2)

Publication Number Publication Date
EP1212066A1 EP1212066A1 (en) 2002-06-12
EP1212066A4 true EP1212066A4 (en) 2004-03-03

Family

ID=22522916

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00952657A Ceased EP1212066A4 (en) 1999-08-09 2000-08-09 Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids

Country Status (3)

Country Link
EP (1) EP1212066A4 (en)
CA (1) CA2378620A1 (en)
WO (1) WO2001010448A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0103695D0 (en) * 2001-11-07 2001-11-07 Thomas Boren A novel non-antibiotic strategy against OGIP infections based on a cereal product
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
CN108949643A (en) * 2018-08-31 2018-12-07 重庆子和杉农业发展有限公司 A kind of cultivation the rabbit method of lactic acid bacteria and the method for nuisanceless feeding rabbit

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482926A (en) * 1992-06-08 1996-01-09 Pharmacia Ab Growth factor IGF-Il
WO1996029083A1 (en) * 1995-03-23 1996-09-26 Probi Ab Epithelial adhesive lactobacilli
WO1997030717A1 (en) * 1996-02-26 1997-08-28 Arla Ekonomisk Förening Adhesion inhibitors, preparation comprising them and method for producing them
WO1998035014A2 (en) * 1997-02-11 1998-08-13 Enterprise Ireland Trading As Bioresearch Ireland Probiotic strains from lactobacillus salivarius and antimicrobial agents obtained therefrom
EP0861905A2 (en) * 1997-02-27 1998-09-02 Proge Farm S.r.l. Novel lactobacilli strains useful in the treatment of disorders of the gastrointestinal system
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
WO1999018188A1 (en) * 1997-10-03 1999-04-15 Probi Ab Feed product
WO2000041707A2 (en) * 1999-01-15 2000-07-20 Enterprise Ireland (Trading As Bioresearch Ireland) USE OF $i(LACTOBACILLUS SALIVARIUS)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5413960A (en) * 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
SE8900546D0 (en) * 1989-02-17 1989-02-17 Bioinvent Int Ab Means for inhibiting pathogens' growth and / or survival
GB2261372A (en) * 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection
US5413785A (en) * 1993-01-27 1995-05-09 New England Deaconess Hospital Corp. Methodology employing lactobacillus GG for reduction of plasma endotoxin levels circulating in-vivo
JPH0892112A (en) * 1994-09-28 1996-04-09 Yakult Honsha Co Ltd Cytokine production promoter

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482926A (en) * 1992-06-08 1996-01-09 Pharmacia Ab Growth factor IGF-Il
WO1996029083A1 (en) * 1995-03-23 1996-09-26 Probi Ab Epithelial adhesive lactobacilli
WO1997030717A1 (en) * 1996-02-26 1997-08-28 Arla Ekonomisk Förening Adhesion inhibitors, preparation comprising them and method for producing them
WO1998035014A2 (en) * 1997-02-11 1998-08-13 Enterprise Ireland Trading As Bioresearch Ireland Probiotic strains from lactobacillus salivarius and antimicrobial agents obtained therefrom
EP0861905A2 (en) * 1997-02-27 1998-09-02 Proge Farm S.r.l. Novel lactobacilli strains useful in the treatment of disorders of the gastrointestinal system
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
WO1999018188A1 (en) * 1997-10-03 1999-04-15 Probi Ab Feed product
WO2000041707A2 (en) * 1999-01-15 2000-07-20 Enterprise Ireland (Trading As Bioresearch Ireland) USE OF $i(LACTOBACILLUS SALIVARIUS)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JUNG HYUN CHAE ET AL: "A distinct Array of Proinflammatory Cytokines is expressed in Human Colon Epithelial Cells in Response to bacterial Invasion", JOURNAL OF CLINICAL INVESTIGATION, vol. 95, January 1995 (1995-01-01), pages 55 - 65 *
See also references of WO0110448A1 *

Also Published As

Publication number Publication date
EP1212066A1 (en) 2002-06-12
CA2378620A1 (en) 2001-02-15
WO2001010448A1 (en) 2001-02-15

Similar Documents

Publication Publication Date Title
AU7602400A (en) Secreted proteins and uses thereof
AU1473501A (en) 21 human secreted proteins
AU1438001A (en) 27 human secreted proteins
AU1604401A (en) 18 human secreted proteins
AU2001237958A1 (en) 22 human secreted proteins
AU1448701A (en) 15 human secreted proteins
AU1334101A (en) 19 human secreted proteins
AU2001227833A1 (en) 71 human secreted proteins
AU2002232596A1 (en) Secreted human proteins
AU6394400A (en) Secreted proteins and uses thereof
AU2001245308A1 (en) 207 human secreted proteins
AU2001237957A1 (en) 17 human secreted proteins
AU2002211220A1 (en) Secreted proteins and their uses
EP1212066A4 (en) Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids
AU1342501A (en) 32 human secreted proteins
EP1189938A4 (en) Secreted proteins and uses thereof
AU2001290551A1 (en) Secreted proteins and their uses
AU2001294719A1 (en) Secreted human proteins
AU3382800A (en) Secreted proteins and uses thereof
AU2001284651A1 (en) Secreted proteins and methods of using same
AU1190801A (en) Secreted proteins and uses thereof
WO2000069885A8 (en) Secreted proteins and uses thereof
AU2001283327A1 (en) 8 human secreted proteins
AU2001229507A1 (en) 21 human secreted proteins
AU2001255668A1 (en) 29 human secreted proteins

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020308

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20040115

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12R 1/225 B

Ipc: 7A 61K 39/07 B

Ipc: 7C 07K 14/335 B

Ipc: 7A 61K 35/74 A

17Q First examination report despatched

Effective date: 20041012

17Q First examination report despatched

Effective date: 20041012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20090324